Topics:
Breast Cancer • Medical Oncology
How do you determine which HER-2 positive patients should receive neoadjuvant chemotherapy?
Would you give neoadjuvant chemotherapy in a patient with T1 N1 M0 ER/HER-2 positive cancer if they are candidates for upfront lumpectomy?
Answer from: Medical Oncologist at Academic Institution
Chemotherapy in combination with anti-HER2 antibodies should be recommended to a patient with node positive, HER2 positive breast cancer. Since NSABP B18 and B27 showed no difference in long term outcomes between patients treated with neo-adjuvant vs. adjuvant chemotherapy, you can go either way. I ...
Sign in or Register to read more